Medication

FDA approves Tylenol® with Naproxen, the first and only over-the-counter fixed-dose combination of acetaminophen (650 mg) and naproxen sodium (220 mg)

July 25, 2026

FDA-approved first and only OTC fixed‑dose combination of acetaminophen and naproxen sodium, expanding non-opioid options for persistent pain.Addresses…

MMedication

GLP-1 drugs reshaping fitness: UAE experts stress strength training is key

July 25, 2026

For decades, the fitness industry revolved around one goal — helping people lose weight. Today, the growing popularity…

MMedication

Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills

July 25, 2026

(Gray News) — An over-the-counter allergy medication sold nationwide is being recalled for a mix-up with another medication…

MMedication

Raleigh-area patient hopeful of new FDA-approved cholesterol pill

July 25, 2026

RALEIGH, N.C. (WTVD) — For nearly two years, Steve Church has been working with doctors to keep his…

MMedication

FDA peptide votes could open the door to more unproven drugs: ‘Pandora’s box’

July 24, 2026

A Food and Drug Administration advisory committee on Friday recommended allowing two more unproven peptides to be compounded,…

MMedication

New GLP-1 Clinical Study Finds Calocurb Reduces Body Weight and Fat. (Image Credit: Calocurb, a 100% natural, prescription-free GLP-1 activator. Business Wire)

July 24, 2026

Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, recently announced the publication…

MMedication

July 24, 2026

The first cohort of MPharm pharmacist prescribers received their General Pharmaceutical Council (GPhC) registration results this week, with…

MMedication

Is a peptide boom underway? FDA advisers vote for looser rules

July 24, 2026

A majority of outside advisers for the Food and Drug Administration voted Thursday in support of allowing pharmacies…

MMedication

The billion-dollar problem keeping Ozempic, Wegovy, and Zepbound from patients

July 24, 2026

GLP-1 medications have been shown to improve health and offer strong value for their price, yet many insurance…

MMedication

Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills | Local News

July 24, 2026

LOUISVILLE, Ky. (WDRB/Gray Media) — An over-the-counter allergy medication sold nationwide is being recalled for a mix-up with another…

MMedication

Can Ozempic rewire the addicted brain? : NPR

July 24, 2026

Part 1 of the TED Radio Hour episode Rethinking addiction in the age of Ozempic GLP-1s revolutionized weight-loss and diabetes…

MMedication

We're reading about GLP-1 drugs for addiction, FDA funding

July 24, 2026

And so, another working week will soon draw to a close. Not a moment too soon, yes? This…

FDA approves Tylenol® with Naproxen, the first and only over-the-counter fixed-dose combination of acetaminophen (650 mg) and naproxen sodium (220 mg)

GLP-1 drugs reshaping fitness: UAE experts stress strength training is key

Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills

Raleigh-area patient hopeful of new FDA-approved cholesterol pill

FDA peptide votes could open the door to more unproven drugs: ‘Pandora’s box’

New GLP-1 Clinical Study Finds Calocurb Reduces Body Weight and Fat » World Business Outlook

Health news round-up: coffee, ADHD prescribing, and GLP-1s and hair loss

Is a peptide boom underway? FDA advisers vote for looser rules

The billion-dollar problem keeping Ozempic, Wegovy, and Zepbound from patients

Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills | Local News

Can Ozempic rewire the addicted brain? : NPR

Pharmalittle: FDA panel backs pharmacies to make peptides